Nevertheless, many studies show that the use of IL18 binding protein (IL18BP, a soluble protein that binds to IL18), which will neutralize the effects of this interleukin, may have a positive therapeutic effect on cancer [69]. The gene discussed is IL18BP; the disease is cancer.